High Costs of Biotechnology

In Chapter 2 of Sally Smith Hughes' Genetech, the third part of the Genetech trio is introduced. Arthur Swanson was a young venture capitalist who had a special interest in recombinant DNA. He decided that there was a financial future in this new biotechnology field, and it could possibly be lucrative. It happens that Swanson was right, but not only in the case of Genetech. Biotechnology as a field has become wildly successful, and in massive need of huge amounts of venture capital. This article summarizes the amounts of capital invested in the state of Maryland, during the last quarter of 2015. In second place was biotech. Maryland companies such as "Precision for Medicine INC" pulled upwards of $75 million in venture capital. This local company that focuses on ways to personalize healthcare, was the second largest consumer of capital in the last quarter of 2015, in the state of Maryland. This revolutionary sector has proven to be a high consumer of venture capital, like Swanson predicted. It has become even larger than he could have ever predicted, and even more influential.
High Costs of Biotechnology

Leave a Reply